Advanced search
Publication Cover
Leukemia & Lymphoma Volume 63, 2022 - Issue 5
Submit an article Journal homepage
219
Views
0
CrossRef citations to date
0
Altmetric
Letters to the Editor

Radioimmunotherapy for orbital marginal zone lymphoma: a retrospective review

Andrea C. Loa Department of Radiation Oncology, British Columbia Cancer Vancouver, Vancouver, Canada;b Department of Surgery, University of British Columbia (UBC), Vancouver, Canada;c BC Cancer Centre for Lymphoid Cancer, Vancouver, CanadaCorrespondence[email protected]
ORCID Iconhttps://orcid.org/0000-0002-3253-1071
ORCID Icon,
Caroline L. Hollowayb Department of Surgery, University of British Columbia (UBC), Vancouver, Canada;c BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada;d Department of Radiation Oncology, British Columbia Cancer Victoria, Victoria, CanadaORCID Iconhttps://orcid.org/0000-0003-3089-2006
ORCID Icon,
Kerry J. Savagec BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada;e Department of Medical Oncology, British Columbia Cancer, Vancouver, Canada;f Department of Medicine, University of British Columbia (UBC), Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-5835-9863
ORCID Icon,
Laurie H. Sehnc BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada;e Department of Medical Oncology, British Columbia Cancer, Vancouver, Canada;f Department of Medicine, University of British Columbia (UBC), Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0003-1860-9765
ORCID Icon,
Daniel F. Worsleyg Department of Nuclear Medicine, Vancouver General Hospital, Vancouver, Canada
,
Joseph M. Connorsc BC Cancer Centre for Lymphoid Cancer, Vancouver, Canada;e Department of Medical Oncology, British Columbia Cancer, Vancouver, Canada;f Department of Medicine, University of British Columbia (UBC), Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-1361-7531
ORCID Icon &
Tom Picklesa Department of Radiation Oncology, British Columbia Cancer Vancouver, Vancouver, Canada;b Department of Surgery, University of British Columbia (UBC), Vancouver, Canada;c BC Cancer Centre for Lymphoid Cancer, Vancouver, CanadaORCID Iconhttps://orcid.org/0000-0002-2040-4630
ORCID Icon show all
Pages 1242-1245 | Received 08 Mar 2022, Accepted 22 Mar 2022, Published online: 05 May 2022

References

  • McKelvie PA. Ocular adnexal lymphomas: a review. Adv Anat Pathol. 2010;17(4):251–261.
  • Esmaeli B, McLaughlin P, Pro B, et al. Prospective trial of targeted radioimmunotherapy with Y-90 ibritumomab tiuxetan (zevalin) for front-line treatment of early-stage extranodal indolent ocular adnexal lymphoma. Ann Oncol. 2009;20(4):709–714.
  • Morschhauser F, Radford J, Van Hoof A, et al. Phase III trial of consolidation therapy with yttrium-90-ibritumomab tiuxetan compared with no additional therapy after first remission in advanced follicular lymphoma. J Clin Oncol. 2008;26(32):5156–5164.
  • Kaminski MS, Tuck M, Estes J, et al. 131I-tositumomab therapy as initial treatment for follicular lymphoma. N Engl J Med. 2005;352(5):441–449.
  • Holloway C, Pickles T, Croteau N, et al. Treatment outcomes of low grade lymphoma of the orbit. Clin Oncol. 2022.
  • Yahalom J, Illidge T, Specht L, et al. Modern radiation therapy for extranodal lymphomas: field and dose guidelines from the International Lymphoma Radiation Oncology Group. Int J Radiat Oncol Biol Phys. 2015;92(1):11–31.
  • Desai A, Joag MG, Lekakis L, et al. Long-term course of patients with primary ocular adnexal MALT lymphoma: a large single-institution cohort study. Blood. 2017;129(3):324–332.
  • Hoskin PJ, Kirkwood AA, Popova B, et al. 4 Gy versus 24 Gy radiotherapy for patients with indolent lymphoma (FORT): a randomised phase 3 non-inferiority trial. Lancet Oncol. 2014;15(4):457–463.
  • Hoskin P, Popova B, Schofield O, et al. 4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. Lancet Oncol. 2021;22(3):332–340.
  • Pinnix CC, Dabaja BS, Milgrom SA, et al. Ultra-low-dose radiotherapy for definitive management of ocular adnexal B-cell lymphoma. Head Neck. 2017;39(6):1095–1100.
  • Lo AC, James LP, Prica A, et al. Positron-emission tomography-based staging is cost-effective in early-stage follicular lymphoma. J Nucl Med. 2021.
  • Yong JHE, McGowan T, Redmond-Misner R, et al. Estimating the costs of intensity-modulated and 3-dimensional conformal radiotherapy in Ontario. Curr Oncol. 2016;23(3):e228–e238.
  • Bayraktar S, Bayraktar UD, Stefanovic A, et al. Primary ocular adnexal mucosa-associated lymphoid tissue lymphoma (MALT): single institution experience in a large cohort of patients. Br J Haematol. 2011;152(1):72–80.
  • Goda JS, Gospodarowicz M, Pintilie M, et al. Long-term outcome in localized extranodal mucosa-associated lymphoid tissue lymphomas treated with radiotherapy. Cancer. 2010;116(16):3815–3824.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.